279 related articles for article (PubMed ID: 26678348)
1. Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.
Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Rujescu D; Kasper S; Lanzenberger R
Hum Brain Mapp; 2016 Mar; 37(3):884-95. PubMed ID: 26678348
[TBL] [Abstract][Full Text] [Related]
2. The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.
Vanicek T; Spies M; Rami-Mark C; Savli M; Höflich A; Kranz GS; Hahn A; Kutzelnigg A; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Volkow ND; Kasper S; Lanzenberger R
JAMA Psychiatry; 2014 Dec; 71(12):1340-1349. PubMed ID: 25338091
[TBL] [Abstract][Full Text] [Related]
3. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
[TBL] [Abstract][Full Text] [Related]
4. Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET.
Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Berroterán-Infante N; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hartmann AM; Hacker M; Rujescu D; Kasper S; Lanzenberger R
Mol Psychiatry; 2021 Mar; 26(3):1009-1018. PubMed ID: 31383926
[TBL] [Abstract][Full Text] [Related]
5. Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.
Park MH; Kim JW; Yang YH; Hong SB; Park S; Kang H; Kim BN; Shin MS; Yoo HJ; Cho SC
Neurosci Lett; 2012 Apr; 514(2):159-63. PubMed ID: 22405810
[TBL] [Abstract][Full Text] [Related]
6. A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).
Ramoz N; Boni C; Downing AM; Close SL; Peters SL; Prokop AM; Allen AJ; Hamon M; Purper-Ouakil D; Gorwood P
Neuropsychopharmacology; 2009 Aug; 34(9):2135-42. PubMed ID: 19387424
[TBL] [Abstract][Full Text] [Related]
7. Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[
Ulke C; Rullmann M; Huang J; Luthardt J; Becker GA; Patt M; Meyer PM; Tiepolt S; Hesse S; Sabri O; Strauß M
Transl Psychiatry; 2019 Nov; 9(1):301. PubMed ID: 31732713
[TBL] [Abstract][Full Text] [Related]
8. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.
Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Höflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
Hum Brain Mapp; 2017 Feb; 38(2):792-802. PubMed ID: 27770470
[TBL] [Abstract][Full Text] [Related]
9. Norepinephrine Transporter in Major Depressive Disorder: A PET Study.
Moriguchi S; Yamada M; Takano H; Nagashima T; Takahata K; Yokokawa K; Ito T; Ishii T; Kimura Y; Zhang MR; Mimura M; Suhara T
Am J Psychiatry; 2017 Jan; 174(1):36-41. PubMed ID: 27631962
[TBL] [Abstract][Full Text] [Related]
10. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
Seneca N; Gulyás B; Varrone A; Schou M; Airaksinen A; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
Psychopharmacology (Berl); 2006 Sep; 188(1):119-27. PubMed ID: 16896954
[TBL] [Abstract][Full Text] [Related]
11. Further evidence of association between two NET single-nucleotide polymorphisms with ADHD.
Kim JW; Biederman J; McGrath CL; Doyle AE; Mick E; Fagerness J; Purcell S; Smoller JW; Sklar P; Faraone SV
Mol Psychiatry; 2008 Jun; 13(6):624-30. PubMed ID: 17876324
[TBL] [Abstract][Full Text] [Related]
12. PET Quantification of the Norepinephrine Transporter in Human Brain with (
Moriguchi S; Kimura Y; Ichise M; Arakawa R; Takano H; Seki C; Ikoma Y; Takahata K; Nagashima T; Yamada M; Mimura M; Suhara T
J Nucl Med; 2017 Jul; 58(7):1140-1145. PubMed ID: 27980046
[TBL] [Abstract][Full Text] [Related]
13. The possible involvement of genetic variants of NET1 in the etiology of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
Liu L; Cheng J; Li H; Yang L; Qian Q; Wang Y
J Child Psychol Psychiatry; 2015 Jan; 56(1):58-66. PubMed ID: 24942521
[TBL] [Abstract][Full Text] [Related]
14. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.
Lee SH; Kim SW; Lee MG; Yook KH; Greenhill LL; Fradin KN; Hong HJ
Psychiatry Res; 2011 Apr; 186(2-3):338-44. PubMed ID: 20863575
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography neuroimaging for a better understanding of the biology of ADHD.
Zimmer L
Neuropharmacology; 2009 Dec; 57(7-8):601-7. PubMed ID: 19682469
[TBL] [Abstract][Full Text] [Related]
17. Association of norepinephrine transporter (NET, SLC6A2) genotype with ADHD-related phenotypes: findings of a longitudinal study from birth to adolescence.
Hohmann S; Hohm E; Treutlein J; Blomeyer D; Jennen-Steinmetz C; Schmidt MH; Esser G; Banaschewski T; Brandeis D; Laucht M
Psychiatry Res; 2015 Apr; 226(2-3):425-33. PubMed ID: 25724484
[TBL] [Abstract][Full Text] [Related]
18. Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.
Hahn MK; Steele A; Couch RS; Stein MA; Krueger JJ
Neuropharmacology; 2009 Dec; 57(7-8):694-701. PubMed ID: 19698724
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of norepinephrine transporter in the human brain using PET with (S,S)-18F-FMeNER-D2.
Arakawa R; Okumura M; Ito H; Seki C; Takahashi H; Takano H; Nakao R; Suzuki K; Okubo Y; Halldin C; Suhara T
J Nucl Med; 2008 Aug; 49(8):1270-6. PubMed ID: 18632811
[TBL] [Abstract][Full Text] [Related]
20. Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.
Li CS; Potenza MN; Lee DE; Planeta B; Gallezot JD; Labaree D; Henry S; Nabulsi N; Sinha R; Ding YS; Carson RE; Neumeister A
Neuroimage; 2014 Feb; 86():306-10. PubMed ID: 24121204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
